VP
venBio Partners Portfolio holdings
AUM
$115M
This Quarter Return
+34.55%
1 Year Return
-33.99%
3 Year Return
+221.07%
5 Year Return
+224.54%
10 Year Return
–
AUM
$162M
AUM Growth
+$162M
(+61%)
Cap. Flow
+$54.9M
Cap. Flow
% of AUM
33.85%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
VYNE Therapeutics
VYNE
|
$54.9M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 51.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
VYNE Therapeutics
VYNE
$8.16M
| $54.9M | 33.85% | +1,461,552 | New | +$54.9M |
|
|
VRNA
2
Verona Pharma
VRNA
$9.16B
| $17.5M | 10.79% | 875,000 | – | – |
|
|
NBRV
3
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $10.7M | 6.58% | 2,122,962 | – | – |
|